Coherus BioSciences, Inc. reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported net loss was USD 38.53 million compared to net income of USD 27.93 million a year ago. Basic loss per share from continuing operations was USD 0.49 compared to basic earnings per share from continuing operations of USD 0.39 a year ago. Diluted loss per share from continuing operations was USD 0.49 compared to diluted earnings per share from continuing operations of USD 0.33 a year ago. For the nine months, net loss was USD 241.38 million compared to net income of USD 122.54 million a year ago. Basic loss per share from continuing operations was USD 3.22 compared to basic earnings per share from continuing operations of USD 1.72 a year ago. Diluted loss per share from continuing operations was USD 3.22 compared to diluted earnings per share from continuing operations of USD 1.52 a year ago.